As per MRFR analysis, the Ophthalmic Viscoelastic Devices Market Size was estimated at 2.04 (USD Billion) in 2023. The Ophthalmic Viscoelastic Devices Market Industry is expected to grow from 2.13(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The Ophthalmic Viscoelastic Devices Market CAGR (growth rate) is expected to be around 4.62% during the forecast period (2025 - 2035).
The Global Ophthalmic Viscoelastic Devices Market is experiencing significant trends driven by various factors. One of the key market drivers is the increasing prevalence of eye diseases such as cataracts and glaucoma. As populations age, the demand for surgical procedures is rising, thereby boosting the need for ophthalmic viscoelastic devices. Technological advancements in these devices, contributing to improved surgical outcomes and patient safety, further support market growth.
Opportunities to be explored include the development of innovative viscoelastic materials and the expansion of product lines tailored to specific eye conditions. Research and development in biodegradable options offer the potential for creating devices that enhance comfort and reduce complications during the surgical process.
Furthermore, there is a substantial opportunity for market expansion due to the increasing awareness and accessibility of eye care services in developing regions. In recent years, the market landscape has been influenced by trends such as the increased adoption of minimally invasive surgical techniques. This has resulted in a greater emphasis on the function of viscoelastic devices in these procedures, as surgeons prefer to employ less invasive methods.
For example, the global healthcare sector's transition to outpatient surgeries is consistent with the implementation of sophisticated ophthalmic viscoelastic devices that expedite patient recovery times.
The collective endeavor to improve ocular health on a global scale is evidenced by the increase in healthcare expenditure in various regions and government initiatives aimed at improving eye care. This dynamic environment is expected to propitiate ongoing innovation and expansion in the global market for ophthalmic viscoelastic devices.
  
 Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Global Ophthalmic Viscoelastic Devices Market Industry is projected to grow significantly due to the rising prevalence of eye disorders such as cataracts and glaucoma.
According to the World Health Organization, approximately 285 million people worldwide are visually impaired, with cataracts accounting for around 51% of all cases. This alarming statistic illustrates the growing need for effective surgical procedures where ophthalmic viscoelastic devices play a crucial role in maintaining eye structure during surgeries.
Prominent organizations such as the American Academy of Ophthalmology are actively engaged in research and awareness programs, further driving the demand for these devices. With a continued increase in the global aging population, this trend will undoubtedly escalate the market for ophthalmic viscoelastic devices requiring innovative solutions.
Technological breakthroughs in minimally invasive surgical techniques are expected to propel the Global Ophthalmic Viscoelastic Devices Market Industry. The evolution of phacoemulsification and advanced viscoelastic formulations allows surgeons to perform complex eye surgeries more efficiently. The shift towards robotic-assisted surgeries, supported by various medical associations and educational platforms, is enhancing the precision of ophthalmic procedures.
A report from the European Society of Cataract and Refractive Surgeons indicated that about 95% of cataract surgeries are now performed using minimally invasive methods, signifying a robust shift toward increased adoption of viscoelastic devices, which play a critical role in these innovative techniques.
With increasing healthcare expenditure globally, particularly in emerging markets, the Global Ophthalmic Viscoelastic Devices Market Industry is anticipated to thrive. The World Bank reported an annual increase in global healthcare spending, which emphasizes the focus on enhancing healthcare systems, including eye care.
Countries such as India and Brazil are investing significantly in healthcare infrastructure, providing citizens with better access to ophthalmic treatments.
As more people seek eye care solutions, the demand for ophthalmic viscoelastic devices will rise as they are essential for surgical procedures. Establishments like the World Health Organization stress the importance of investing in eye health programs, enhancing the market landscape further.
The Global Ophthalmic Viscoelastic Devices Market, particularly within the Product Type segment, demonstrates notable segmentation into Hydrophobic, Hydrophilic, and Combination categories. In 2024, the Hydrophobic products are projected to generate a revenue of 0.85 USD Billion, steadily increasing to 1.4 USD Billion by 2035.
This segment shows significant importance due to its high compatibility with various surgical techniques, which enhances the operational efficiency in ocular surgeries, thus demonstrating a majority holding in the market's growth trajectory.
The Hydrophilic segment is estimated to contribute 0.9 USD Billion in 2024, growing to 1.45 USD Billion in 2035. This segment is characterized by its ability to provide stable intraocular pressure, thus being critical in cataract and other ocular procedures, reinforcing its significant role within the market.
The Combination products, which encompass both hydrophobic and hydrophilic characteristics, are anticipated to reach a valuation of 0.38 USD Billion in 2024 and 0.65 USD Billion by 2035. Though this segment holds a smaller market share compared to its counterparts, it brings unique benefits and flexibility to surgical applications.
Overall, the Global Ophthalmic Viscoelastic Devices Market segmentation illustrates how each type fulfills specific surgical needs and operational efficiencies, consequently supporting a compound annual growth rate that underscores ongoing advancements in ophthalmic surgical practices.
The growth of these segments is driven by technological advancements in the medical field, an aging global population necessitating more eye surgeries, and a rising prevalence of ophthalmic disorders, presenting ample opportunities for industry stakeholders to innovate further and capture emerging market share.
  
 Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Global Ophthalmic Viscoelastic Devices Market is projected to reach a value of 2.13 billion USD by 2024, showcasing the growing demand and utilization of these devices in various applications. The market is extensively divided into key areas such as Cataract Surgery, Corneal Surgery, Glaucoma Surgery, and Refractive Surgery.
Each of these applications plays a decisive role in driving advancements and innovations in ophthalmic surgeries. Among them, Cataract Surgery constitutes a significant portion of the market, often leading in terms of device adoption due to the high prevalence of cataracts globally.
Corneal Surgery benefits from the use of viscoelastic devices to maintain ocular pressure and protect corneal cells during procedures, making it pivotal for patient outcomes. Glaucoma Surgery is also critical, as these devices help in minimizing trauma and aiding in the management of intraocular pressures. Furthermore, Refractive Surgery is gaining traction, with a focus on correcting vision defects, thus expanding the potential applications of viscoelastic materials.
The overall growth in the Global Ophthalmic Viscoelastic Devices Market reflects the trends towards more minimally invasive surgeries and technological advancements tailored to improve surgical outcomes for patients worldwide.
The Global Ophthalmic Viscoelastic Devices Market has shown substantial growth, with a revenue of 2.13 USD Billion projected for 2024. The End User segment plays a crucial role in this growth, consisting of Hospitals, Ambulatory Surgical Centers, and Ophthalmic Clinics.
Hospitals dominate this segment due to their comprehensive services and facilities, accommodating a wide range of eye surgeries, which boosts the demand for ophthalmic viscoelastic devices. Ambulatory Surgical Centers have gained significance as they offer cost-effective and efficient surgical services, focusing on outpatient care.
This trend is driven by the increasing need for minimally invasive procedures, which require specialized devices. Ophthalmic Clinics also play a vital part as they provide focused and specialized eye care, contributing to the overall market growth. The expected market growth is influenced by factors such as an aging population, rising prevalence of eye disorders, and advancements in ophthalmic technologies, thereby making the End User segment a pivotal area in the Global Ophthalmic Viscoelastic Devices Market industry.
With the increasing collaboration among healthcare providers and device manufacturers, opportunities for expansion within these segments remain promising, reinforcing their importance and driving the Global Ophthalmic Viscoelastic Devices Market statistics forward.
The Global Ophthalmic Viscoelastic Devices Market is increasingly categorized by Formulation Type, primarily divided into Single-Use and Multi-Use varieties. As of 2024, the market is recognized for its significant valuation, and it is projected to continue its upward trend towards 2035.
The preference for Single-Use devices has gained traction due to a heightened focus on infection control and product sterility, which are critical factors in ocular surgery. This formulation type is especially important as it minimizes cross-contamination risks, thereby ensuring patient safety.
Conversely, multi-use devices are also prevalent, offering cost-efficiency and accessibility. The demand for these formulations is largely driven by advancements in surgical techniques and an increasing number of ophthalmic procedures performed globally. With a compound annual growth rate (CAGR) of 4.62 percent expected between 2025 and 2035, the Global Ophthalmic Viscoelastic Devices Market showcases robust growth potential across these Formulation Types.
The landscape reflects an ongoing emphasis on innovating device compositions and adapting to evolving healthcare needs, underscoring the importance of both Single-Use and Multi-Use formulations in the industry.
The Regional analysis of the Global Ophthalmic Viscoelastic Devices Market reveals significant variances in market valuation and growth potential across different areas. In 2024, North America holds a majority share, valued at 0.9 USD Billion, and is forecasted to rise to 1.5 USD Billion by 2035.
This region's well-established healthcare infrastructure and high patient awareness drive its dominance. Europe follows, valued at 0.55 USD Billion in 2024, with an increase to 0.9 USD Billion by 2035, benefiting from advanced Research and Development initiatives.
The APAC region, valued at 0.4 USD Billion in 2024, is projected to reach 0.74 USD Billion by 2035, showcasing a robust growth trajectory due to rising demand for surgical procedures.
South America, valued at 0.15 USD Billion in 2024, and MEA, at 0.13 USD Billion, represent smaller markets, reflecting emerging opportunities in improving healthcare access and economic development with expected valuations of 0.25 USD Billion and 0.21 USD Billion, respectively, by 2035.
The Global Ophthalmic Viscoelastic Devices Market data illustrates the importance of addressing regional differences to capitalize on market growth and leverage opportunities effectively.
  
 Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Global Ophthalmic Viscoelastic Devices Market is experiencing notable competitive dynamics due to the increasing demand for eye surgeries and advancements in surgical technologies.
This market is characterized by a variety of players offering products designed to enhance surgical procedures and promote patient safety and comfort. Competitive insights reveal a landscape where innovation plays a crucial role, with companies focusing on developing superior viscoelastic materials that offer optimal properties for ophthalmic applications.
The competitive edge is often determined by the ability to introduce new products that meet regulatory standards while addressing the evolving needs of the surgical field. Companies are also striving for strategic partnerships, mergers, and acquisitions to consolidate their position in the market and expand their product portfolios.
Abbott Laboratories stands out in the Global Ophthalmic Viscoelastic Devices Market with a strong reputation for quality and innovation. The company's focus on research and development has enabled it to introduce a range of advanced viscoelastic products tailored for various ophthalmic procedures, including cataract surgery and vitreoretinal surgery. Abbott Laboratories has a robust market presence, supported by its established distribution networks and partnerships with healthcare providers worldwide. Its strengths lie in its ability to deliver consistent product quality and effective marketing strategies, which contribute to its competitive position in the market. The company is known for its commitment to meeting the diverse needs of surgeons and patients alike, fostering trust and loyalty in its brand.
Hoya Corporation has also made significant strides in the Global Ophthalmic Viscoelastic Devices Market, leveraging its expertise in optical technologies and materials. The company offers a diverse range of key products and services focused on providing high-quality solutions for ophthalmic surgeries.
Hoya Corporation's strong market presence is bolstered by its strategic focus on innovation and extensive research initiatives aimed at enhancing surgical outcomes. The company's strengths are reflected in its advanced product offerings, such as cohesive and dispersive viscoelastics that are well-regarded for their performance in various surgical scenarios.
Hoya Corporation actively pursues mergers and acquisitions to strengthen its portfolio and enhance its market reach globally, ensuring that it remains a key player in the ophthalmic sector and continues to meet the demands of evolving surgical practices.
The Global Ophthalmic Viscoelastic Devices Market is experiencing notable developments as major companies are focusing on innovation and strategic mergers. Recently, in September 2023, Alcon took a significant step by launching a new line of advanced viscoelastic devices aimed at enhancing surgical outcomes, which is expected to reinforce their market position.
Additionally, Johnson and Johnson has expanded its product portfolio through the acquisition of a technology company specializing in ophthalmic surgical devices, further solidifying its market share in the viscoelastic segment.
In October 2022, Bausch Health Companies announced their collaboration with Harte Hanks to improve marketing strategies and operational execution within ophthalmic products. There has also been a continuous growth trajectory in the market valuation of Abbott Laboratories and Santen Pharmaceutical, paving the way for enhanced research and product development initiatives.
The global market is projected to grow significantly in the coming years owing to increasing cataract surgeries and rising awareness about eye health. These activities underscore an increasingly competitive landscape as companies look to leverage technological advancements and customer insights to capture greater market share.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 2.04(USD Billion) |
| MARKET SIZE 2024 | 2.13(USD Billion) |
| MARKET SIZE 2035 | 3.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.62% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Abbott Laboratories, Hoya Corporation, Oculentis, Carl Zeiss AG, Eyevance Pharmaceuticals, Johnson and Johnson, Santen Pharmaceutical, Alcon, Moria Surgical, Harte Hanks, Ocular Therapeutix, Surgeon Partners, Rayner Surgical, Bausch Health Companies |
| SEGMENTS COVERED | Product Type, Application, End User, Formulation Type, Regional |
| KEY MARKET OPPORTUNITIES | Rising cataract surgeries demand, Innovative product development, Expanding elderly population, Growth in minimally invasive surgeries, Increasing global healthcare expenditure |
| KEY MARKET DYNAMICS | Aging population increase, Rising cataract surgeries, Technological advancements, Growing awareness of eye health, Expanding healthcare infrastructure |
| COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
Ophthalmic Viscoelastic devices Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Ophthalmic Viscoelastic Devices Market is expected to be valued at 2.13 billion USD in 2024.
By 2035, the Global Ophthalmic Viscoelastic Devices Market is projected to reach 3.5 billion USD.
The expected CAGR for the Global Ophthalmic Viscoelastic Devices Market from 2025 to 2035 is 4.62 percent.
In 2024, North America is anticipated to have the largest market share, valued at 0.9 billion USD.
Europe's market share for the Global Ophthalmic Viscoelastic Devices Market is expected to be 0.9 billion USD by 2035.
Key players in the market include Abbott Laboratories, Alcon, and Johnson & Johnson, among others.
The Hydrophobic segment is expected to be valued at 0.85 billion USD in 2024.
The market for Hydrophilic products is projected to grow to 1.45 billion USD by 2035.
Emerging technologies and an aging population present significant growth opportunities in the market.
Regional dynamics significantly influence the growth, with North America leading in market size.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
